The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern.


The p53 gene has been implicated as a tumor-suppressor gene whose disruption is involved in the pathogenesis of common human cancers. The results of extensive analysis of p53 mutations in non-small cell lung cancers (NSCLCs) have revealed that p53 is mutated in 45% of NSCLC with base changes different from those of colon cancer. In this study, we examined… (More)


  • Presentations referencing similar topics